2m 2m 2m 2m 2m 2m 2m
Vycor Medical (VYCO)
OTC
$0.07-$0.0009 (-1.29%)
Price as of May 28, 2026- $2.3MMarket Cap
- -35.29%1-Year Change
- Medical DevicesIndustry
Vycor Medical (VYCO)
$0.07-$0.0009 (-1.29%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.9M +17.24% | 1.6M +8.81% | 1.5M +19.43% | 1.2M -12.20% | |
Cost of Revenue | 302,293 +81.22% | 166,809 +15.08% | 144,950 +3.06% | 140,644 +4.39% | |
Gross Profit | 1.6M +9.74% | 1.4M +8.12% | 1.3M +21.56% | 1.1M -13.98% | |
Sales and Marketing Expense | 1.5M +7.44% | 1.4M +13.50% | 1.2M -10.16% | 1.3M -17.51% | |
Research and Development Expense | -9,963 -34.99% | -15,325 -32.06% | -22,558 N/A | N/A N/A | |
Depreciation and Amortization Expense | 63,143 -1.20% | 63,910 +5.20% | 60,752 -1.06% | 61,403 +441.04% | |
Total Operating Expenses | 1.5M +6.67% | 1.4M +12.25% | 1.3M -8.16% | 1.4M -18.02% | |
Operating Profit | 33,900 +470.69% | -9,145 -122.75% | 40,191 +113.11% | -306,514 -29.69% | |
Interest Income | N/A N/A | 6,002 N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -103,065 +95.70% | -52,664 -5.91% | |
Interest Income and Expense and Net | 0 -100.00% | 6,002 +105.82% | -103,065 +95.70% | -52,664 -5.91% | |
Total Nonoperating Income and Expense | -104,090 +6.42% | -97,806 -5.29% | -103,271 +10.82% | -93,191 -436.37% | |
Income before Taxes | -70,190 -34.37% | -106,951 +69.55% | -63,080 -84.22% | -399,705 -2.09% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -396,796 -8.06% | -431,570 +519.26% | -69,691 -82.79% | -404,917 -7.06% | |
Net Income from Continuing Operations Applicable to Common | -396,796 -8.06% | -431,570 +9.52% | -394,061 -45.97% | -729,287 -4.05% | |
Basic EPS and Net Income | -0.01 0.00% | -0.01 0.00% | -0.01 -50.00% | -0.02 -33.33% | |
Diluted EPS and Net Income | -0.01 0.00% | -0.01 0.00% | -0.01 -50.00% | -0.02 -33.33% | |
Basic Weighted Average Shares | 33.4M +1.48% | 32.9M +0.86% | 32.6M +2.82% | 31.7M +7.02% | |
Diluted Weighted Average Shares | 33.4M +1.48% | 32.9M +0.86% | 32.6M +2.82% | 31.7M +7.02% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 86,982 -17.67% | 105,648 +84.41% | 57,291 +54.69% | 37,035 -59.28% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 86,982 -17.67% | 105,648 +84.41% | 57,291 +54.69% | 37,035 -59.28% | |
Total Current Assets | 563,422 -19.02% | 695,719 +19.11% | 584,090 +12.81% | 517,763 +6.23% | |
Accumulated Depreciation | 1.3M +5.22% | 1.2M +5.58% | 1.1M +5.60% | 1.1M +6.00% | |
Property and Plant and Equipment and Net | 133,936 -30.49% | 192,693 -23.66% | 252,404 -16.91% | 303,770 -16.18% | |
Total Long-Term Assets | 133,062 +21.29% | 109,705 -56.54% | 252,404 -16.91% | 303,770 -16.18% | |
Total Assets | 830,420 -16.80% | 998,117 +0.59% | 992,298 +15.36% | 860,178 -8.04% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 326,978 +0.86% | 324,185 -75.35% | 1.3M +166.54% | 493,373 +53.76% | |
Total Current Liabilities | 4.8M +6.34% | 4.5M +10.36% | 4.1M +11.48% | 3.7M +16.03% | |
Total Long-Term Debt | 135,831 -2.59% | 139,436 -2.43% | 142,908 -2.29% | 146,253 -2.50% | |
Total Long-Term Liabilities | 188,052 +260.11% | 52,221 -47.98% | 100,379 -31.37% | 146,253 -19.01% | |
Total Liabilities | 4.9M +4.89% | 4.7M +8.58% | 4.3M +13.59% | 3.8M +14.13% | |
Retained Earnings | -33.6M +1.19% | -33.3M +1.31% | -32.8M +1.22% | -32.4M +2.30% | |
Total Stockholders Equity | -4.1M +10.75% | -3.7M +10.96% | -3.3M +13.08% | -2.9M +22.78% | |
Total Shares Outstanding | 33.4M 0.00% | 33.4M +2.28% | 32.6M +0.31% | 32.5M +5.54% | |
Cash Flow | |||||
Cash from Operating Activities | -13,471 -122.41% | 60,110 +104.25% | 29,430 +113.56% | -217,016 -1,115.56% | |
Capital Expenditures | 5,224 +24.41% | 4,199 -55.26% | 9,386 +237.63% | 2,780 -92.76% | |
Cash from Investing Activities | -4,383 +4.38% | -4,199 -55.26% | -9,386 +237.63% | -2,780 -92.76% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -812 -89.25% | -7,554 -3,680.09% | 211 -99.87% | 165,889 +167.80% | |
Financials Ratio | |||||
Gross Margin | 83.78% -6.40% | 89.50% -0.63% | 90.08% +1.78% | 88.50% -2.02% | |
Operating Margin | 1.82% +416.18% | -0.58% -120.91% | 2.75% +110.98% | -25.06% -19.92% | |
Return on Assets | -43.40% +0.08% | -43.36% +476.35% | -7.52% -83.32% | -45.10% -0.52% | |
Return on Equity | 10.20% -17.06% | 12.30% +453.13% | 2.22% -85.34% | 15.18% -23.77% | |
Revenue Growth | 17.24% +95.68% | 8.81% -54.64% | 19.43% +259.20% | -12.20% -155.54% | |
Current Ratio | 0.12 -23.85% | 0.15 +7.88% | 0.14 +1.20% | 0.14 -8.40% | |
Cash Ratio | 0.02 -22.55% | 0.02 +66.67% | 0.01 +39.60% | 0.01 -65.05% | |
Debt-to-Equity Ratio | -0.11 -9.87% | -0.13 -71.35% | -0.44 +101.56% | -0.22 +10.63% | |
Debt-to-Assets Ratio | 0.56 +19.98% | 0.46 -68.38% | 1.47 +97.58% | 0.74 +47.72% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow